home / stock / otlk / otlk short
Short Information | Outlook Therapeutics Inc. (NASDAQ:OTLK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,147,449 |
Total Actual Volume | 5,594,443 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 57,372 |
Average Short Percentage | 20.55% |
Is there a OTLK Short Squeeze or Breakout about to happen?
See the OTLK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-31-2024 | $7.26 | $7.07 | $7.35 | $6.89 | 166,599 | 33,330 | 20.01% |
05-30-2024 | $7.18 | $7.22 | $7.28 | $6.99 | 233,461 | 48,786 | 20.9% |
05-29-2024 | $7.8 | $7.13 | $7.8 | $7.105 | 256,835 | 31,405 | 12.23% |
05-28-2024 | $7.62 | $7.935 | $7.95 | $7.05 | 661,628 | 145,804 | 22.04% |
05-24-2024 | $7.59 | $7.9 | $7.95 | $7.38 | 228,601 | 51,549 | 22.55% |
05-23-2024 | $8 | $7.53 | $8.18 | $7.34 | 247,818 | 53,065 | 21.41% |
05-22-2024 | $7.83 | $8 | $8.3 | $7.83 | 319,959 | 48,349 | 15.11% |
05-21-2024 | $7.95 | $7.87 | $8.04 | $7.62 | 192,096 | 51,371 | 26.74% |
05-20-2024 | $7.71 | $7.95 | $8.05 | $7.68 | 236,478 | 33,291 | 14.08% |
05-17-2024 | $7.34 | $7.78 | $7.92 | $7.1801 | 187,970 | 44,036 | 23.43% |
05-16-2024 | $7.14 | $7.33 | $7.36 | $6.798 | 399,708 | 79,683 | 19.94% |
05-15-2024 | $7.46 | $7.43 | $7.57 | $7.345 | 225,179 | 37,962 | 16.86% |
05-14-2024 | $7.62 | $7.4 | $7.82 | $7.29 | 225,343 | 50,600 | 22.45% |
05-13-2024 | $7.57 | $7.54 | $8.13 | $7.5 | 400,795 | 45,252 | 11.29% |
05-10-2024 | $7.75 | $7.58 | $7.825 | $7.5253 | 392,664 | 106,293 | 27.07% |
05-09-2024 | $8.18 | $7.73 | $8.18 | $7.6016 | 223,914 | 64,040 | 28.6% |
05-08-2024 | $8.2 | $8 | $8.26 | $7.81 | 452,630 | 99,021 | 21.88% |
05-07-2024 | $8.61 | $8.21 | $8.76 | $8.17 | 200,305 | 40,847 | 20.39% |
05-06-2024 | $8.91 | $8.5 | $8.91 | $8.4501 | 241,170 | 65,950 | 27.35% |
05-03-2024 | $8.57 | $8.6 | $8.88 | $8.515 | 101,290 | 16,815 | 16.6% |
News, Short Squeeze, Breakout and More Instantly...
Outlook Therapeutics Inc. Company Name:
OTLK Stock Symbol:
NASDAQ Market:
LYTENAVA™ (bevacizumab gamma) becomes first ophthalmic formulation of bevacizumab to receive European Commission Marketing Authorization for the treatment of wet AMD European Commission decision applies automatically to all 27 EU Member States and, within 30 days, also to Iceland, ...
2024-05-16 12:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ (bevacizumab gamma) United Kingdom (UK) Marketing Authorization Application (MAA) submitted NORSE EIGHT fully underway in the U...